Agilent Technologies, Inc. $A Shares Bought by Raiffeisen Bank International AG

Raiffeisen Bank International AG boosted its stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 7.6% during the 2nd quarter, Holdings Channel reports. The firm owned 73,572 shares of the medical research company’s stock after acquiring an additional 5,209 shares during the quarter. Raiffeisen Bank International AG’s holdings in Agilent Technologies were worth $9,773,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $26,000. SHP Wealth Management purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $27,000. Cedar Mountain Advisors LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at $27,000. Finally, MV Capital Management Inc. purchased a new position in Agilent Technologies in the 4th quarter worth $28,000.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on A. JPMorgan Chase & Co. lifted their price target on Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. The Goldman Sachs Group raised their price objective on Agilent Technologies from $155.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Finally, Sanford C. Bernstein upped their target price on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $170.33.

Get Our Latest Report on Agilent Technologies

Agilent Technologies Trading Down 1.0%

NYSE A opened at $149.87 on Friday. The company has a market capitalization of $42.25 billion, a PE ratio of 29.50, a P/E/G ratio of 2.30 and a beta of 1.24. The company has a fifty day moving average of $141.99 and a 200 day moving average of $127.71. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.